Company Overview of Blue Ash Therapeutics, LLC
Blue Ash Therapeutics, LLC develops Azimilide, an oral once-daily cardiac antiarrhythmic drug. The company was founded in 2008 and is based in Cincinnati, Ohio. As of April 19, 2011, Blue Ash Therapeutics, LLC operates as a subsidiary of Forest Laboratories Holdings Limited.
4555 Lake Forest Drive
Cincinnati, OH 45242
Founded in 2008
Key Executives for Blue Ash Therapeutics, LLC
Similar Private Companies By Industry
|Genotec Nutritionals, Inc.||United States|
|Scherer R P International Corp||United States|
|Prokaryon Technologies, Inc.||United States|
|Ariel Pharmaceuticals, Inc.||United States|
|Vaxess Technologies Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Blue Ash Therapeutics, LLC, please visit www.blueashtx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.